RNAZ - Financial Reports List - TransCode Therapeutics, Inc. - IntrinsicAlpha

TransCode Therapeutics, Inc. RNAZ

Healthcare - Biotechnology - NASDAQ - US

$ 0.3109

10.1 %

$ 7.26 M

Market Cap

None

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Annual Report	FY	10-K	2024-12-31	0.00%	9.49%	19.35%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	56.20%	59.35%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-19.56%	0.33%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	30.87%	32.12%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	77.80%	26.57%
Annual Report	FY	10-K	2023-12-31	0.00%	47.21%	-4.03%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-23.55%	-7.55%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	6.33%	-9.00%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-38.97%	-40.94%
Quarterly Report	Q4	8-K	2022-12-31	0.00%	-108.38%	-85.10%

1